Cicero, Arrigo F.G.

Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

Hay, S. I., Ong, K. L., Santomauro, D. F., A, B., Aalipour, M. A., Aalruz, H., Ababneh, H. S., Abaraogu, U. O., Abate, B. B., Abbafati, C., et al. (2025) · The Lancet

Global Health and EpidemiologyCardiovascular Health and Risk Factors

Cited by 916

Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

Naghavi, M., Kyu, H. H., A, B., Aalipour, M. A., Aalruz, H., Ababneh, H. S., Abafita, B. J., Abaraogu, U. O., Abbafati, C., Abbasi, M., et al. (2025) · The Lancet

Insurance, Mortality, Demography, Risk ManagementGlobal Health and Epidemiology

Cited by 595

Berberine and Its Role in Chronic Disease

Cicero, A. F. G., & Baggioni, A. (2016) · Advances in Experimental Medicine and Biology

Berberine and alkaloids researchTraditional Chinese Medicine Analysis

Cited by 285

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

Cicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O., Djuric, D. M., Ezhov, M., Fras, Z., Katsiki, N., Langlois, M., Latkovskis, G., et al. (2017) · Archives of Medical Science

Lipoproteins and Cardiovascular HealthNatural Products and Biological Research

Cited by 281

The Role of Nutraceuticals in Statin Intolerant Patients

Banach, M., Patti, A. M., Giglio, R. V., Cicero, A. F. G., Atanasov, A. G., Bajraktari, G., Bruckert, E., Descamps, O., Djuric, D. M., Ezhov, M., et al. (2018) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthNatural Products and Biological Research

Cited by 272

Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review

Caliceti, C., Calabria, D., Roda, A., & Cicero, A. (2017) · Nutrients

Diet, Metabolism, and DiseaseGout, Hyperuricemia, Uric Acid

Cited by 236

Bioactive peptides in cereals and legumes: agronomical, biochemical and clinical aspects.

Malaguti, M., Dinelli, G., Leoncini, E., Bregola, V., Bosi, S., Cicero, A., & Hrelia, S. (2014) · International Journal of Molecular Sciences

Protein Hydrolysis and Bioactive PeptidesProteins in Food Systems

Cited by 180

Berberine on metabolic and cardiovascular risk factors: An analysis from preclinical evidences to clinical trials

Derosa, G., Maffioli, P., & Cicero, A. F. (2012) · Expert Opinion on Biological Therapy

Berberine and alkaloids researchNatural Antidiabetic Agents Studies

Cited by 171

Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050

Micah, A. E., Cogswell, I. E., Cunningham, B., Ezoe, S., Harle, A. C., Maddison, E. R., McCracken, D., Nomura, S., Simpson, K. E., Stutzman, H. N., et al. (2021) · The Lancet

Global Health Care IssuesInternational Development and Aid

Cited by 162

Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper

Poli, A., Barbagallo, C. M., Cicero, A. F. G., Corsini, A., Manzato, E., Trimarco, B., Bernini, F., Visioli, F., Bianchi, A., Canzone, G., et al. (2018) · Pharmacological Research

Lipoproteins and Cardiovascular HealthNatural Products and Biological Research

Cited by 134

Efficacy and Safety of Mipomersen: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Fogacci, F., Ferri, N., Toth, P. P., Ruscica, M., Corsini, A., & Cicero, A. F. G. (2019) · Drugs

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 132

Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects

Derosa, G., D’Angelo, A., Tinelli, C., Devangelio, E., Consoli, A., Miccoli, R., Penno, G., Del Prato, S., Paniga, S., & Cicero, A. F. G. (2007) · Diabetes & Metabolism

Protease and Inhibitor MechanismsAdipokines, Inflammation, and Metabolic Diseases

Cited by 129

Exenatide Versus Glibenclamide in Patients with Diabetes

Derosa, G., Maffioli, P., Salvadeo, S. A. T., Ferrari, I., Ragonesi, P. D., Querci, F., Franzetti, I. G., Gadaleta, G., Ciccarelli, L., Piccinni, M. N., et al. (2010) · Diabetes Technology & Therapeutics

Diabetes Treatment and ManagementAdipokines, Inflammation, and Metabolic Diseases

Cited by 125

Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?

Cicero, A. F. G., Fogacci, F., Stoian, A. P., Vrablik, M., Al Rasadi, K., Banach, M., Toth, P. P., & Rizzo, M. (2021) · Current Atherosclerosis Reports

Lipoproteins and Cardiovascular HealthNatural Products and Biological Research

Cited by 110

A Randomized Placebo-Controlled Clinical Trial to Evaluate the Medium-Term Effects of Oat Fibers on Human Health: The Beta-Glucan Effects on Lipid Profile, Glycemia and inTestinal Health (BELT) Study

Cicero, A. F. G., Fogacci, F., Veronesi, M., Strocchi, E., Grandi, E., Rizzoli, E., Poli, A., Marangoni, F., & Borghi, C. (2020) · Nutrients

Food composition and propertiesMicrobial Metabolites in Food Biotechnology

Cited by 106

A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence

Barrios, V., Escobar, C., Cicero, A. F. G., Burke, D., Fasching, P., Banach, M., & Bruckert, E. (2017) · Atherosclerosis Supplements

Lipoproteins and Cardiovascular HealthNatural Products and Biological Research

Cited by 96

Lipid-lowering activity of artichoke extracts: A systematic review and meta-analysis

Sahebkar, A., Pirro, M., Banach, M., Mikhailidis, D. P., Atkin, S. L., & Cicero, A. F. G. (2018) · Critical Reviews in Food Science and Nutrition

Cynara cardunculus studiesNatural Products and Biological Research

Cited by 86

Updated trends in the global prevalence and burden of mental disorders, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

Santomauro, D. F., Miller, P. A., Shadid, J., Wulf Hanson, S., Vo, A., Roy, D. J., Hagins, H., Mantilla Herrera, A. M., Scott, J. G., Erskine, H. E., et al. (2026) · The Lancet

Mental Health Treatment and AccessGlobal Health and Epidemiology

Cited by 83

Nutrients and Nutraceuticals for the Management of High Normal Blood Pressure: An Evidence-Based Consensus Document

Cicero, A. F. G., Grassi, D., Tocci, G., Galletti, F., Borghi, C., & Ferri, C. (2019) · High Blood Pressure & Cardiovascular Prevention

Blood Pressure and Hypertension StudiesSodium Intake and Health

Cited by 79

Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: The available clinical data

Cicero, A. F. G., & Colletti, A. (2016) · Phytomedicine

Natural Products and Biological ResearchLipoproteins and Cardiovascular Health

Cited by 70

Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients

Derosa, G., Cicero, A. F. G., Murdolo, G., Piccinni, M. N., Fogari, E., Bertone, G., Ciccarelli, L., & Fogari, R. (2005) · Diabetes, Obesity and Metabolism

Pharmacology and Obesity TreatmentBlood Pressure and Hypertension Studies

Cited by 67

Non-pharmacological control of plasma cholesterol levels

Poli, A., Marangoni, F., Paoletti, R., Mannarino, E., Lupattelli, G., Notarbartolo, A., Aureli, P., Bernini, F., Cicero, A., Gaddi, A., et al. (2008) · Nutrition, Metabolism and Cardiovascular Diseases

Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Cited by 63

Metabolic effect of berberine–silymarin association: A meta‐analysis of randomized, double‐blind, placebo‐controlled clinical trials

Fogacci, F., Grassi, D., Rizzo, M., & Cicero, A. F. G. (2019) · Phytotherapy Research

Berberine and alkaloids researchNatural Antidiabetic Agents Studies

Cited by 61

Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia

Banerjee, Y., Pantea Stoian, A., Cicero, A. F. G., Fogacci, F., Nikolic, D., Sachinidis, A., Rizvi, A. A., Janez, A., & Rizzo, M. (2022) · Expert Opinion on Drug Safety

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 54